-
Dorsomorphin 2HCl: From AMPK to Translation
2026-09-09
Dorsomorphin 2HCl is more than a routine AMPK inhibitor: it can function as a causal stress test for metabolic phenotypes while also opening research paths through BMP signaling, osteogenic differentiation, hepcidin expression regulation, and iron homeostasis. This thought-leadership guide connects the compound’s mechanism with the recent Lactiplantibacillus plantarum P101 liver study and translates those findings into stronger experimental and translational strategies.
-
FGF-19, FGFR4, and the Next Frontier in Renal Signaling
2026-09-08
WIP1–p38 MAPK–pyroptosis research provides a compelling mechanistic framework for sepsis-associated acute kidney injury, while Recombinant Human FGF-19 offers a controlled way to test whether endocrine FGFR4 signaling intersects with renal inflammatory injury. This article distinguishes established evidence from testable hypotheses and outlines a receptor-aware workflow for translational researchers.
-
SU6656 Src Tyrosine Kinases Inhibitor Workflows
2026-09-08
SU6656 provides a practical way to interrogate Src-dependent signaling in mitogenesis, megakaryocyte maturation, and radiation response. This evidence-led workflow separates established product applications from testable strategies for iPSC-derived platelet research and radiotherapy sensitization.
-
PMSF Workflows for Protein Integrity
2026-09-07
Phenylmethanesulfonyl fluoride (PMSF) provides targeted, irreversible serine protease control during protein extraction and Western blot sample preparation. This guide connects practical PMSF handling with modern GSPT1 degrader studies, showing how better lysate preservation can strengthen degradation, signaling, and apoptosis assays without confusing sample protection with mechanism of action.
-
Tetracycline Hydrochloride: Assay Workflows
2026-09-07
Build more reproducible antimicrobial assays with Tetracycline Hydrochloride by controlling solvent, exposure time, and bacteriostatic readouts. This guide connects Staphylococcus aureus, Propionibacterium acnes, and microbiome applications with practical lessons from rapid ROS-based cancer nanodrug research—without conflating distinct mechanisms.
-
EdU Imaging Kits (Cy3): S-Phase Workflow
2026-09-05
EdU Imaging Kits (Cy3) turn short DNA-replication pulses into bright, denaturation-free readouts for microscopy and flow cytometry. This practical guide shows how to apply the assay to cholangiocarcinoma drug studies, combination-treatment experiments, genotoxicity testing, and troubleshooting-driven method development.
-
ONX-0914 (PR-957) Assay Guide
2026-09-04
This scenario-driven guide explains how ONX-0914 (PR-957), SKU A4011, can support interpretable viability, proliferation, and cytokine experiments through selective immunoproteasome inhibition. It covers assay compatibility, solvent handling, dose interpretation, and practical criteria for comparing research-grade products.
-
Testosterone Bounce in Degarelix-Treated Prostate Cancer
2026-09-04
A 2024 retrospective study found that testosterone bounce, defined by recovery above 20 ng/dL after suppression below that level, was associated with better overall and cancer-specific survival in men receiving degarelix. The findings support evaluating testosterone dynamics alongside PSA, while the retrospective design means the biomarker is prognostic rather than yet clinically validated for treatment decisions.
-
8-Chloroadenosine in RNA Research Workflows
2026-09-03
8-Chloroadenosine is a practical pharmacological perturbation tool for testing how transcriptional output shapes mRNA stability, lncRNA function, and cancer-cell behavior. This workflow-focused guide connects its RNA synthesis inhibition to the RP3-340N1.2–IL-6 axis in NSCLC while emphasizing dose finding, controls, and interpretation limits.
-
Oteseconazole (VT-1161): CYP51 Evidence Guide
2026-09-03
Oteseconazole, also known as VT-1161, is a selective tetrazole CYP51 inhibitor with potent in-vitro activity against multiple Candida species. Its strongest translational use is targeted antifungal research and prevention of recurrent vulvovaginal candidiasis, while species-specific limits and assay conditions must be considered.
-
Red Blood Cell Membrane Bending Rigidity
2026-09-02
Himbert and colleagues separated the bending response of the red blood cell cytoplasmic membrane from that of the spectrin network by combining X-ray diffuse scattering, neutron spin-echo spectroscopy, and molecular dynamics simulations. Their estimate of approximately 4–6 kBT explains why whole-cell measurements span a much broader range and provides a more precise foundation for interpreting red blood cell deformability.
-
Z-VDVAD-FMK for Caspase-2 Apoptosis Workflows
2026-09-02
Z-VDVAD-FMK gives researchers a cell-permeable, irreversible way to test whether caspase-2 contributes to mitochondrial and nuclear apoptosis rather than relying on a generic viability endpoint. This practical guide connects inhibitor setup, orthogonal apoptosis readouts, and the latest SVA–DDX23 findings to help distinguish caspase-dependent signaling from residual caspase-independent death.
-
Prestained Protein Marker for RA Neuron Studies
2026-09-01
Use a Triple color protein ladder to track electrophoresis, confirm transfer, and orient fluorescent Western blots in sensory-neuron signaling experiments. Its 10–250 kDa range and EDTA-free formulation make it particularly useful for pSTAT3 workflows that combine Phosbind SDS-PAGE, membrane imaging, and translational sample comparison.
-
EZ Cap™ Human PTEN mRNA (ψUTP) Guide
2026-09-01
A practical workflow for using Cap 1, pseudouridine-modified PTEN mRNA to study tumor-suppressor restoration, pathway control, and delivery performance. Learn how to connect in vitro transcribed mRNA expression assays with nanoparticle-enabled cancer research while avoiding common RNA handling and interpretation errors.
-
ECL Chemiluminescent Substrate Detection Kit (Enhanced)
2026-08-31
The ECL Chemiluminescent Substrate Detection Kit (Enhanced), SKU K1230, is intended to improve low-abundance protein immunodetection in western blots using directly or indirectly HRP-labeled antibodies. It should be used for HRP-based chemiluminescence workflows, not as a substitute for transfer, antibody-specificity, loading, or imaging controls and not for non-HRP detection systems.